复发性滤泡性淋巴瘤-话题@MedSci

#复发性滤泡性淋巴瘤#

4篇内容 | 670人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1694675, encodeId=b4a616946e5ec, content=<a href='/topic/show?id=4aad4254e05' target=_blank style='color:#2F92EE;'>#复发性滤泡性淋巴瘤#</a>, objectTitle=HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响, objectType=article, longId=727501, objectId=ccafe275011b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccafe275011b, replyNumber=0, likeNumber=36, createdTime=2022-07-07, rootId=0, userName=chenwq18, userId=3b4729711287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccafe275011b, moduleTitle=HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccafe275011b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694674, encodeId=6fff16946e493, content=<a href='/topic/show?id=4aad4254e05' target=_blank style='color:#2F92EE;'>#复发性滤泡性淋巴瘤#</a>, objectTitle=Blood：CD19 CAR-T细胞免疫疗法有助于难治性/复发性滤泡性淋巴瘤患者获得持久的缓解, objectType=article, longId=173300, objectId=ce3d1e330034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce3d1e330034, replyNumber=0, likeNumber=24, createdTime=2019-08-17, rootId=0, userName=chenwq18, userId=3b4729711287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce3d1e330034, moduleTitle=Blood：CD19 CAR-T细胞免疫疗法有助于难治性/复发性滤泡性淋巴瘤患者获得持久的缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce3d1e330034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694673, encodeId=4b0416946e3a8, content=<a href='/topic/show?id=4aad4254e05' target=_blank style='color:#2F92EE;'>#复发性滤泡性淋巴瘤#</a>, objectTitle=治疗复发性滤泡性淋巴瘤的新疗法, objectType=article, longId=113010, objectId=afe9113010c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe9113010c9, replyNumber=0, likeNumber=32, createdTime=2017-12-28, rootId=0, userName=chenwq18, userId=3b4729711287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe9113010c9, moduleTitle=治疗复发性滤泡性淋巴瘤的新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afe9113010c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694672, encodeId=374b16946e2e1, content=<a href='/topic/show?id=4aad4254e05' target=_blank style='color:#2F92EE;'>#复发性滤泡性淋巴瘤#</a>, objectTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, objectType=article, longId=78484, objectId=c96ee84848f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c96ee84848f, replyNumber=0, likeNumber=31, createdTime=2017-07-12, rootId=0, userName=chenwq18, userId=3b4729711287, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c96ee84848f, moduleTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c96ee84848f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

chenwq18 (审核中...)

前往app查看评论内容

#复发性滤泡性淋巴瘤#

HAEMATOLOGICA：PET-CT状态对接受自体干细胞移植的复发性滤泡性淋巴瘤患者无进展生存期的影响

2022-07-07

chenwq18 (审核中...)

前往app查看评论内容

#复发性滤泡性淋巴瘤#

Blood：CD19 CAR-T细胞免疫疗法有助于难治性/复发性滤泡性淋巴瘤患者获得持久的缓解

2019-08-17

chenwq18 (审核中...)

前往app查看评论内容

#复发性滤泡性淋巴瘤#

治疗复发性滤泡性淋巴瘤的新疗法

2017-12-28

chenwq18 (审核中...)

前往app查看评论内容

#复发性滤泡性淋巴瘤#

2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布

2017-07-12

科室
- - 订阅+
  - 更多科室
工具
服务